AnaptysBio Announces Third Quarter 2021 Financial Results
Imsidolimab GPP GALLOP Phase 2 16-week data presented at 2021 EADV Congress and GEMINI-1 Phase 3 trial initiated subsequent to FDA end-of-Phase 2...
United States Johann Gudjonsson Dennis Mulroy Hamza Suria Bristol Myers Squibb European Academy Of Dermatology
Source: globenewswire.com